JP2021519261A5 - - Google Patents
Info
- Publication number
- JP2021519261A5 JP2021519261A5 JP2020551257A JP2020551257A JP2021519261A5 JP 2021519261 A5 JP2021519261 A5 JP 2021519261A5 JP 2020551257 A JP2020551257 A JP 2020551257A JP 2020551257 A JP2020551257 A JP 2020551257A JP 2021519261 A5 JP2021519261 A5 JP 2021519261A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- seq
- composition
- inhibitor
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862645847P | 2018-03-21 | 2018-03-21 | |
| US62/645,847 | 2018-03-21 | ||
| US201862782480P | 2018-12-20 | 2018-12-20 | |
| US62/782,480 | 2018-12-20 | ||
| PCT/US2019/023461 WO2019183415A1 (en) | 2018-03-21 | 2019-03-21 | Compositions and methods for cellular reprogramming |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519261A JP2021519261A (ja) | 2021-08-10 |
| JP2021519261A5 true JP2021519261A5 (enExample) | 2022-03-30 |
Family
ID=67988091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551257A Pending JP2021519261A (ja) | 2018-03-21 | 2019-03-21 | 細胞リプログラミングのための組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11512290B2 (enExample) |
| EP (1) | EP3768283A4 (enExample) |
| JP (1) | JP2021519261A (enExample) |
| CA (1) | CA3094658A1 (enExample) |
| WO (1) | WO2019183415A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122374453A (zh) * | 2023-08-02 | 2026-07-10 | 儿童医学中心公司 | 用于治疗与造血干细胞增殖相关联的疾病或病症的对tlr3的靶向 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2591095B1 (en) | 2010-07-08 | 2016-04-27 | Duke University | Direct reprogramming of cells to cardiac myocyte fate |
| CN104781396A (zh) | 2012-01-17 | 2015-07-15 | 小利兰·斯坦福大学托管委员会 | 用于体细胞核重编程的先天免疫激活 |
| WO2014071323A2 (en) | 2012-11-02 | 2014-05-08 | Duke University | Inhibition of histone methyltransferase for cardiac reprogramming |
| WO2014169049A1 (en) * | 2013-04-09 | 2014-10-16 | Duke University | 2' fluoro-modified rnas as immunostimulators |
| US20180042969A1 (en) | 2014-08-07 | 2018-02-15 | Duke University | Compositions and methods for the reprogramming of cells into cardiomyocytes |
| WO2016149358A1 (en) * | 2015-03-16 | 2016-09-22 | Duncan Ross | Method of treatment comprising membrane-enclosed vesicle |
| US11613756B2 (en) * | 2017-04-03 | 2023-03-28 | Duke University | Compositions and methods for differential induction of cell death and interferon expression |
-
2019
- 2019-03-21 JP JP2020551257A patent/JP2021519261A/ja active Pending
- 2019-03-21 US US16/982,964 patent/US11512290B2/en active Active
- 2019-03-21 WO PCT/US2019/023461 patent/WO2019183415A1/en not_active Ceased
- 2019-03-21 CA CA3094658A patent/CA3094658A1/en active Pending
- 2019-03-21 EP EP19770961.1A patent/EP3768283A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5898843B2 (ja) | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 | |
| McDermott et al. | The therapeutic potential of microRNAs: disease modulators and drug targets | |
| Orenes-Piñero et al. | Role of microRNAs in cardiac remodelling: new insights and future perspectives | |
| Wang et al. | Role of microRNAs in cardiac hypertrophy and heart failure | |
| Piccoli et al. | Non-coding RNAs as modulators of the cardiac fibroblast phenotype | |
| US8642751B2 (en) | MicroRNA inhibitors comprising locked nucleotides | |
| MX2014015641A (es) | Inhibidores de la familia mir-15 de micro-arns. | |
| JP2017528441A5 (enExample) | ||
| Mirzadeh Azad et al. | Small molecules with big impacts on cardiovascular diseases | |
| Papageorgiou et al. | Prognostic role of miRNAs in coronary artery disease | |
| US9220724B2 (en) | MicroRNA-based approach to treating malignant pleural mesothelioma | |
| US20230304006A1 (en) | Anti-seed pnas and microrna inhibition | |
| Profumo et al. | Targeting microRNAs to withstand cancer metastasis | |
| US20230129651A1 (en) | Hairpin structure nucleic acid molecules capable of modulating target gene expression and uses thereof | |
| Formosa et al. | Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages | |
| CN104031987B (zh) | miRNA在心肌纤维化疾病治疗中的应用 | |
| KR102897439B1 (ko) | 타겟 유전자 발현을 조절할 수 있는 핵산 분자 및 이의 용도 | |
| CN103316347A (zh) | 微小核苷酸及其拮抗剂或模拟剂在制备抗心肌损伤及纤维化药物中的应用 | |
| CA3094658A1 (en) | Compositions and methods for cellular reprogramming | |
| Nath et al. | From life to death: microRNAs in the fine tuning of the heart |